Clinuvel Pharmaceuticals Quote - CUV

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

11.14

Bid

11.13

Ask

11.14

Volume

122,658

11.06 Day's Range 11.34

10.89 52 Week Range 17.71

Market Cap

558.156M

Previous Close

11.30

Open

11.28

Last Trade

11.14

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

120,859

Shares Outstanding

50,103,765

Dividend Yield

PE Ratio

15.69

Earnings Per Share (EPS)

0.71

Revenue

88.74M

Net Profit

35.64M

Sector

Medicinal Chems,botanicl Pds

Industry

Drugs-health R&d/testing Labs

Website

www.clinuvel.com

Headquarters

Melbourne, Victoria, Aus

Founded

2000

Clinuvel Pharmaceuticals Limited is listed in the Medicinal Chems,botanicl Pds sector of the Australian Stock Exchange with ticker CUV. The last closing price for Clinuvel Pharmaceuticals was AUD11.30. Over the last year, Clinuvel Pharmaceuticals shares have traded in a share price range of AUD 10.89 to AUD 17.71.

Clinuvel Pharmaceuticals currently has 50,103,765 shares outstanding. The market capitalization of Clinuvel Pharmaceuticals is AUD566.17 million. Clinuvel Pharmaceuticals has a price to earnings ratio (PE ratio) of 15.69.

Europe Approves Novel Australian Drug Developed for Rare Sun Disease

The first new pharmaceutical drug invented and developed for an untreated disorder by any Australian company has received regulatory...

Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study

Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study Primary endpoint shows a strong statistical trend in pain-free...

Clinuvel Files European Marketing Authorisation Application for SCENESSE® (afamelanotide)

Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that it has submitted a marketing...

Clinuvel announces positive results of first Phase II US study of SCENESSE® in orphan disease erythropoietic protoporphyria ...

Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY), a global biopharmaceutical company with unique expertise...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.08	-0.713012477718	11.22	11.55	10.89	141553	11.24858815	DE
4	-0.67	-5.67315834039	11.81	12.49	10.89	118509	11.46575087	DE
12	-2.09	-15.7974300831	13.23	13.44	10.89	120859	11.89222922	DE
26	-2.05	-15.5420773313	13.19	15.99	10.89	103414	12.99717728	DE
52	-3.23	-22.4773834377	14.37	17.71	10.89	103144	13.88261449	DE
156	-11.08	-49.8649864986	22.22	28.72	10.89	100515	16.87233521	DE
260	-13.86	-55.44	25	44.67	10.89	119770	20.98000736	DE

CUV - Frequently Asked Questions (FAQ)

What is the current Clinuvel Pharmaceuticals share price?

The current share price of Clinuvel Pharmaceuticals is AUD 11.14

How many Clinuvel Pharmaceuticals shares are in issue?

Clinuvel Pharmaceuticals has 50,103,765 shares in issue

What is the market cap of Clinuvel Pharmaceuticals?

The market capitalisation of Clinuvel Pharmaceuticals is AUD 566.17M

What is the 1 year trading range for Clinuvel Pharmaceuticals share price?

Clinuvel Pharmaceuticals has traded in the range of AUD 10.89 to AUD 17.71 during the past year

What is the PE ratio of Clinuvel Pharmaceuticals?

The price to earnings ratio of Clinuvel Pharmaceuticals is 15.69

What is the cash to sales ratio of Clinuvel Pharmaceuticals?

The cash to sales ratio of Clinuvel Pharmaceuticals is 6.3

What is the reporting currency for Clinuvel Pharmaceuticals?

Clinuvel Pharmaceuticals reports financial results in AUD

What is the latest annual turnover for Clinuvel Pharmaceuticals?

The latest annual turnover of Clinuvel Pharmaceuticals is AUD 88.74M

What is the latest annual profit for Clinuvel Pharmaceuticals?

The latest annual profit of Clinuvel Pharmaceuticals is AUD 35.64M

What is the registered address of Clinuvel Pharmaceuticals?

The registered address for Clinuvel Pharmaceuticals is LEVEL 11, 535 BOURKE STREET, MELBOURNE, VICTORIA, 3000

What is the Clinuvel Pharmaceuticals website address?

The website address for Clinuvel Pharmaceuticals is www.clinuvel.com

Which industry sector does Clinuvel Pharmaceuticals operate in?

Clinuvel Pharmaceuticals operates in the DRUGS-HEALTH R&D/TESTING LABS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PL3OPatagonia Lithium Ltd	AUD 0.009 (800.00%)	713k
ASEOAstute Metals NL	AUD 0.01 (100.00%)	143.39k
CT1Constellation Technologies Limited	AUD 0.002 (100.00%)	264.71k
NRXONoronex Limited	AUD 0.009 (80.00%)	1.38M
SLSOSolstice Minerals Ltd	AUD 0.05 (66.67%)	44.01k
PUROPursuit Minerals Limited	AUD 0.002 (-50.00%)	571.91k
WC1OWest Cobar Metals Ltd	AUD 0.006 (-45.45%)	275.41k
CNDOACondor Energy Ltd	AUD 0.003 (-40.00%)	2.05M
FFGOFatfish Group Limited	AUD 0.002 (-33.33%)	2.98M
TX3Trinex Minerals Ltd	AUD 0.001 (-33.33%)	9.09k
ATHAlterity Therapeutics Ltd	AUD 0.012 (14.29%)	53.38M
PLCPremier1 Lithium Ltd	AUD 0.011 (22.22%)	44.02M
NRXNoronex Limited	AUD 0.019 (18.75%)	29.21M
BTRBrightstar Resources Limited	AUD 0.0205 (-2.38%)	25.21M
MMIMetro Mining Ltd	AUD 0.0525 (-4.55%)	23.46M